Therefore, the CXCL16/CXCR6 axis may be a potential therapeutic target for tumors [38,40,41,42], kidney diseases [36,42], cardiovascular diseases [36,42], non-alcoholic fatty liver disease 43, and autoimmune diseases [37]. This evidence concerns the gene CXCL16 and kidney disorder.